Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [(14)C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers

PURPOSE: To determine the pharmacokinetics of radiolabeled copanlisib (BAY 80-6946) in healthy male volunteers and to investigate the disposition and biotransformation of copanlisib. METHODS: A single dose of 12 mg copanlisib containing 2.76 MBq [(14)C]copanlisib was administered as a 1-h intravenou...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerisch, Michael, Schwarz, Thomas, Lang, Dieter, Rohde, Gabriele, Reif, Stefanie, Genvresse, Isabelle, Reschke, Susanne, van der Mey, Dorina, Granvil, Camille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573760/
https://www.ncbi.nlm.nih.gov/pubmed/28714036
http://dx.doi.org/10.1007/s00280-017-3383-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573760/
https://www.ncbi.nlm.nih.gov/pubmed/28714036
http://dx.doi.org/10.1007/s00280-017-3383-9

Ejemplares similares